652 related articles for article (PubMed ID: 33670518)
1. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.
Abadi AJ; Zarrabi A; Gholami MH; Mirzaei S; Hashemi F; Zabolian A; Entezari M; Hushmandi K; Ashrafizadeh M; Khan H; Kumar AP
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670518
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
3. Correlation of PTEN signaling pathway and miRNA in breast cancer.
Mohammadi M; Fazilat A; Mamalo AS; Ojarudi M; Hemmati-Dinarvand M; Beilankouhi EAV; Valilo M
Mol Biol Rep; 2024 Jan; 51(1):221. PubMed ID: 38281224
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
Wang F; Li L; Chen Z; Zhu M; Gu Y
Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
[TBL] [Abstract][Full Text] [Related]
5. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
6. Thidiazuron suppresses breast cancer via targeting miR-132 and dysregulation of the PI3K-Akt signaling pathway mediated by the miR-202-5p-PTEN axis.
Ibrahim HM; Ismail MB; Ammar RB; Ahmed EA
Biochem Cell Biol; 2021 Jun; 99(3):374-384. PubMed ID: 33103467
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
Hu M; Zhu S; Xiong S; Xue X; Zhou X
Oncol Rep; 2019 Mar; 41(3):1439-1454. PubMed ID: 30628706
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-374b accelerates the development of lung cancer through downregulating PTEN expression via activating PI3K/Akt pathway.
Li J; Zhou Z; Xu FC; Li J; Zeng D; Cao XQ; Han Y
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1116-1124. PubMed ID: 30779080
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-181a/b-1 over-expression enhances osteogenesis by modulating PTEN/PI3K/AKT signaling and mitochondrial metabolism.
Zheng H; Liu J; Tycksen E; Nunley R; McAlinden A
Bone; 2019 Jun; 123():92-102. PubMed ID: 30898695
[TBL] [Abstract][Full Text] [Related]
10. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via PTEN/PI3K/Akt signaling pathway.
Zhang XY; Mao L
Gene; 2021 Jan; 766():145113. PubMed ID: 32891771
[TBL] [Abstract][Full Text] [Related]
12. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
15. circSLC8A1 sponges miR-671 to regulate breast cancer tumorigenesis via PTEN/PI3k/Akt pathway.
Zhu Q; Zhang X; Zai HY; Jiang W; Zhang KJ; He YQ; Hu Y
Genomics; 2021 Jan; 113(1 Pt 1):398-410. PubMed ID: 33301895
[TBL] [Abstract][Full Text] [Related]
16. PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.
Haddadi N; Lin Y; Travis G; Simpson AM; Nassif NT; McGowan EM
Mol Cancer; 2018 Feb; 17(1):37. PubMed ID: 29455665
[TBL] [Abstract][Full Text] [Related]
17. MiR-202-5p/
Liu T; Guo J; Zhang X
Cancer Biol Ther; 2019; 20(7):989-998. PubMed ID: 30983514
[TBL] [Abstract][Full Text] [Related]
18. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
19. Icariin inhibits the malignant progression of lung cancer by affecting the PI3K/Akt pathway through the miR‑205‑5p/PTEN axis.
Zhu F; Ren Z
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35514319
[TBL] [Abstract][Full Text] [Related]
20.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
